Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of new BACE1 inhibitors for treating Alzheimer’s disease
Pragya Kushwaha, Vineeta Singh, Pallavi Somvanshi, et al.
Journal of Molecular Modeling (2021) Vol. 27, Iss. 2
Closed Access | Times Cited: 14

Showing 14 citing articles:

Oxyresveratrol: Sources, Productions, Biological Activities, Pharmacokinetics, and Delivery Systems
Kittisak Likhitwitayawuid
Molecules (2021) Vol. 26, Iss. 14, pp. 4212-4212
Open Access | Times Cited: 65
Navigating the Maze of Alzheimer’s disease by exploring BACE1: Discovery, current scenario, and future prospects
Faiza Iram, Mohammad Shahid, Jaoud Ansari, et al.
Ageing Research Reviews (2024) Vol. 98, pp. 102342-102342
Closed Access | Times Cited: 7
Bioinformatics investigation on blood-based gene expressions of Alzheimer's disease revealed ORAI2 gene biomarker susceptibility: An explainable artificial intelligence-based approach
Karthik Sekaran, Alsamman M. Alsamman, C. George Priya Doss, et al.
Metabolic Brain Disease (2023) Vol. 38, Iss. 4, pp. 1297-1310
Open Access | Times Cited: 9
Exploring the therapeutic potential of rosemary compounds against Alzheimer’s disease through GC-MS and molecular docking analysis
Anjali Singh, Dhananjay Singh, Neeraj Tiwari, et al.
In Silico Pharmacology (2024) Vol. 12, Iss. 2
Closed Access | Times Cited: 2
BACE1 inhibitors: A promising therapeutic approach for the management of Alzheimer’s disease
Richa Arya, Smita Jain, Sarvesh Paliwal, et al.
Asian Pacific Journal of Tropical Biomedicine (2024) Vol. 14, Iss. 9, pp. 369-381
Open Access | Times Cited: 2
News about Therapies of Alzheimer’s Disease: Extracellular Vesicles from Stem Cells Exhibit Advantages Compared to Other Treatments
Jacopo Meldolesi
Biomedicines (2022) Vol. 10, Iss. 1, pp. 105-105
Open Access | Times Cited: 13
Investigating the potential of Juglans regia phytoconstituents for the treatment of cervical cancer utilizing network biology and molecular docking approach
Riya Dua, Tulika Bhardwaj, Irshad Ahmad, et al.
PLoS ONE (2024) Vol. 19, Iss. 4, pp. e0287864-e0287864
Open Access | Times Cited: 1
Systematic analysis to identify novel disease indications and plausible potential chemical leads of glutamate ionotropic receptor NMDA type subunit 1, GRIN1
Tulika Bhardwaj, Irshad Ahmad, Pallavi Somvanshi
Journal of Molecular Recognition (2022) Vol. 36, Iss. 1
Closed Access | Times Cited: 7
In Silico Comparative Exploration of Allergens of Periplaneta americana, Blattella germanica and Phoenix dactylifera for the Diagnosis of Patients Suffering from IgE-Mediated Allergic Respiratory Diseases
Mohd Adnan Kausar, Tulika Bhardwaj, Sadaf Anwar, et al.
Molecules (2022) Vol. 27, Iss. 24, pp. 8740-8740
Open Access | Times Cited: 7
A comprehensive immunoinformatics study to explore and characterize potential vaccine constructs against Ole e 9 allergen of Olea europaea
Mohd Adnan Kausar, Tulika Bhardwaj, Fahaad Alenazi, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 9, pp. 4644-4655
Closed Access | Times Cited: 2
A computational study of buckyballs as potential inhibitors of BACE1 in Alzheimer’s treatment
Thi-Thuy-Huong Le, Phạm Minh Quân, Minh Tam Nguyen, et al.
Chemical Physics Letters (2024) Vol. 854, pp. 141553-141553
Closed Access
Discovery of novel imidazolyl-6,7-dimethoxyisoquinoline derivatives as promising BACE1 inhibitors for management of Alzheimer's disease
Anil Ravi, Bilal O. Alkubaisi, Gourishetty Srikanth, et al.
Journal of Molecular Structure (2024), pp. 141275-141275
Closed Access
Recent Advances in Computational Modeling of BACE1 Inhibitors as Anti-Alzheimer Agents
Konstantinos D. Papavasileiou, F. Dondero, Georgia Melagraki, et al.
Neuromethods (2023), pp. 73-97
Closed Access | Times Cited: 1
Efficacy of Beta-Secretase-1 Enzyme Inhibitors in Alzheimer's Disease
Roohallah Yousefi, Shahla Mokarmian, Ali Jamshidi
Journal of Advanced Pharmacy Research (2023) Vol. 7, Iss. 4, pp. 243-250
Open Access
Page 1

Scroll to top